BI
STRO icon

BVF Inc’s Sutro Biopharma STRO Stock Holding History

BVF Inc’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.2M Buy
+1,251,788
New +$22.6M 0.99% 26
2024
Q1 		– Sell
-334,795
Closed -$14.4M – 69
2023
Q4 		$14.4M Hold
334,795
– – 0.36% 43
2023
Q3 		$11.6M Hold
334,795
– – 0.31% 44
2023
Q2 		$15.6M Hold
334,795
– – 0.43% 39
2023
Q1 		$15.5M Hold
334,795
– – 0.57% 44
2022
Q4 		$27.1M Sell
334,795
-10,000
-3% -$695K 1.14% 31
2022
Q3 		$19.1M Hold
344,795
– – 0.79% 40
2022
Q2 		$18M Hold
344,795
– – 0.87% 34
2022
Q1 		$28.3M Buy
344,795
+252,280
+273% +$24M 1.13% 28
2021
Q4 		$13.8M Buy
92,515
+9,832
+12% +$1.76M 0.5% 47
2021
Q3 		$15.6M Hold
82,683
– – 0.61% 47
2021
Q2 		$15.4M Hold
82,683
– – 0.58% 44
2021
Q1 		$18.8M Sell
82,683
-102,733
-55% -$24.4M 0.71% 34
2020
Q4 		$40.3M Sell
185,416
-123,304
-40% -$20.4M 1.58% 22
2020
Q3 		$31M Buy
308,720
+71,881
+30% +$6.79M 1.69% 24
2020
Q2 		$18.4M Buy
236,839
+189,291
+398% +$18.2M 1.13% 27
2020
Q1 		$4.85M Buy
47,548
+13,028
+38% +$1.37M 0.45% 40
2019
Q4 		$3.8M Buy
34,520
+100
+0.3% +$10.3K 0.29% 47
2019
Q3 		$3.13M Buy
+34,420
New +$3.48M 0.33% 50

Other funds holding STRO

AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

BVF Inc's STRO Position: Q1 2026 in Review

BVF Inc opened a new position in Sutro Biopharma (STRO) in Q1 2026: 1,251,788 shares worth $31.2M. The stake represents 0.99% of the portfolio and ranks #26 among its holdings. This is a return to the name: BVF Inc previously reported a position in STRO as recently as Q4 2023.

BVF Inc first reported a position in STRO in Q3 2019 and has held it in 19 quarters since. The position peaked at $40.3M in Q4 2020. 78 funds tracked by Wall St. Rank hold STRO as of Q1 2026.

  • BVF Inc held 1,251,788 shares of Sutro Biopharma worth $31.2M as of Q1 2026.
  • Sutro Biopharma was a new BVF Inc position in Q1 2026.
  • Sutro Biopharma made up 0.99% of BVF Inc's portfolio in Q1 2026, its #26 holding.
  • BVF Inc first reported a position in Sutro Biopharma in Q3 2019 and has held it in 19 quarters since.
  • BVF Inc's Sutro Biopharma position peaked at $40.3M in Q4 2020.
  • 78 funds tracked by Wall St. Rank held Sutro Biopharma as of Q1 2026.

Based on BVF Inc's 13F filing for Q1 2026, filed 15 May 2026.